Mixed Q2 for Humana: Earnings Beat and Cost Control, but No Guidance Raise Sparks Selloff

Humana posts $7.61 adjusted EPS, topping estimates as costs remain in line; shares decline after full-year guidance is reaffirmed without an increase.